Consumer Health Sales And Earnings Roundup: Prestige, GNC, USANA, Omega Protein
This article was originally published in The Tan Sheet
Executive Summary
Prestige would stretch distribution for European growth; GNC prioritizes increasing franchises; co-pilots at USANA helm to manage growth; Omega Protein grows on acquisition.
You may also be interested in...
Industry News Roundup
Reckitt looks to “friend” consumers on Facebook; InterHealth acquires 7-Keto; regulators interested in adverse event reporting; CRN tool reveals enforcement trends; FDA food advisors take on risk assessments; and more consumer health care product industry news.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.